|
CANDRIAM EQUITIES L BIOTECHNOLOGY V2 | Umbrella Fund | Candriam Equities L | Currency | USD | Dates | Promoter | | Country | LUX | Inception | 28/08/2020 | | Nature | SICAV | Closing | - | EP Category | Equity biotechnology | ISIN | LU2026682919 | Rating category | Equity biotechnology | Etoiles EuroPerformance | |
|
|
|
Europerformance Categories | | | Ss Family : | Equity themes and sectors |
| | | | | | | Cat : | Equity biotechnology |
|
| | |
|
| | NAV | Date | 11/06/2024 | VL | 1 872.49 | Variation | 0.08 | Currency | USD | Net Assets (at the end of the month) | 17.298 (Million €) | Total Net asset (subfund level)(end of month) | only to registered users |
|
| | Evolution of the NAV | |
|
|
|
Management | Management company | Candriam Sca | Custodian | Caceis Bank (Lux) | | | | | Risk profile | | Accum. / Distri. | Accumulation | Frequency | Daily | Frequency of the dividends | | Geographical investment zone | World | Max. management fees | 0.75% |
|
| | Marketing countries | Distributed CHE | | Distributed FRA | | Distributed ITA | | Distributed LUX | |
|
| | | Accumulation fund | |
|
|
|
|
Subscription / Redemption | Subscription fees | Redemption fees | Min / Max | Fixed 0.00 % | Min / Max | Fixed 0.00 % | dedicated to the fund | - | dedicated to the fund | - | Subscription | Unknown price | Redemption | Unknown price | Recommended minimum investment period | At least 72 Month |
|
|
|
|
|
|
|
|